Global Clinical Trial Management Systems Market Welcomes the Cloud

Clinical trial management systems (CTMS) are a vital tool in medical research utilized to streamline the data collection process in clinical trials in order to make the data more easily manageable and accessible. In modern times, clinical trial management software is rapidly becoming the norm in the healthcare and pharmaceutical industry due to the increased accuracy and ease of use it provides over conventional methods of data storage. The ever-present need of medicine to have its data refined as finely as possible before clinical utilization has made clinical trial management systems a crucial tool in clinical trial protocol. 

Browse Report: http://www.transparencymarketresearch.com/clinical-trial-management-systems-market.html

The global market for clinical trial management systems is expected to reflect the rising importance of clinical trial management systems in the global healthcare sector, according to Transparency Market Research. The market intelligence firm projects a sturdy 14% CAGR for the global CTMS market from 2013 to 2019, with the market’s valuation expected to rise from US$844 mn to more than US$1.8 bn in that period. 

How influential are cloud-based clinical trial management systems for the global market?

Currently, web-based delivery of clinical trial management systems is the most popular delivery mode. However, the independent storage offered by cloud infrastructure has made cloud-based CTMS the fastest growing segment of the global market. The future of the global CTMS market is likely to feature cloud services prominently, as the global presence of cloud infrastructure improves steadily. 

Recently, global pharmaceutical giant, Pfizer, announced its plans to utilize Oracle’s cloud services across their catalog of more than 300 clinical trials every year. This allows Pfizer to focus its core power into the generation of clinical data and outsource its administration. This is an increasingly popular choice in the global pharmaceutical industry and is likely to play a determinant role in the future of the global clinical trial management systems market in the 2013-2019 forecast period.

How will the increasing investment in life sciences and pharmaceutical research affect the global CTMS market?

The increasing investment in the global pharmaceutical and life sciences sector is a major driver for the global clinical trial management systems market. The need for all kinds of commodities has grown due to the growing global population, while the increasing diversity of demographics and social and economic classes has made healthcare data increasing difficult to track. The increasing pollution and the high prevalence of the almost-stereotypically unhealthy urban lifestyle have also made various lifestyle diseases more prevalent than ever before. This has led to clinical research exhibiting a steady rise all over the world, with the global clinical trial management systems market set to benefit massively from this in the coming years. 

Which is the dominant regional segment of the global CTMS market?

Currently, North America leads the global clinical trial management systems market due to the firm establishment of several pharmaceutical industry giants in the region. However, the expanding Asia Pacific market for pharmaceutical, cosmetic, and nutritional products has made it the dominant force in the global CTMS market. The development of cloud-based smart city infrastructure in leading Asian economies such as China, India, and Japan could thus have a crucial part to play in the development of the region’s clinical trial management systems market.

You can purchase and download the full report here

Novel Application Areas of Smart Glasses and Windows to Increase their Demand Globally

Smart glasses and windows are manufactured from a special type of glass that brings about a change in the total amount of light transmitted through it in terms of heat or light and supplied voltage. Smart glasses and windows have gained traction due to their quality of thermal and acoustic insulation, energy consumption, and elegant 3D designer proposition. They also assist in maintaining temperatures and hence avoid the consumption of additional electricity. Initially, these were employed only in buildings for architectural purposes, but now their applications have also expanded into the rail, automotive, and aviation sectors.

Transparency Market Research (TMR) throws light on the major factors impacting the growth of the market, the key technologies, and major players in the market. It also elaborates on the areas wherein this technology has been implemented.

Q. What is the impact of the major drivers and inhibitors in the global smart glass and window market?

Smart glasses and windows provide passenger comfort and fuel efficiency within marine, aircraft, and automotive sectors. The increasing sales of luxury cars has emerged as a prime factor fuelling the demand for smart glasses in cars, thus boosting the market. Furthermore, the growing requirement for energy efficiency within buildings and the increasing energy crisis will also positively impact the development of the market.

The soaring demand from Asia Pacific and the expanding application areas of smart glasses and windows are the key growth opportunities in the market. On the other hand, the soaring cost of smart glasses is a major factor that may inhibit the development of this market in the developing regions, however, they are still bound to gain traction from the developed nations globally.

Q. Which technologies have emerged as the major investment pockets for the chief players and why?

In terms of technology, suspended particle device (SPD) currently holds the largest share in the market. This is owing to the fact that SPD smart windows prevent the creation of hazy appearances and inhibit light transmission by up to 99.5%. In addition, the rising per capita income and the growing proliferation of enterprise wearable devices globally has increased the adoption of this sophisticated technology in both transportation and construction sectors. Research Frontiers Inc. is the prime player in the SPD technology. This company holds a license list for more than forty companies, amongst which the top companies are Hitachi Chemical Co, Mercedes-Benz, DuPont, Polaroid, and Pilkington.

Q. What steps have been taken by some of the nations for regulating the adoption of smart glasses within electronic equipment?

The use of smart glasses and windows is the highest in the automotive sector. For instance, the suspended particles smart glass technology is gaining high traction within premium cars such as Mercedes Benz SLK, etc. However, governments in some of the nations have taken crucial steps for regulating the adoption of smart glasses owing to certain limitations of smart glasses. In the EU territories and the U.S., governments have planned on regulating the deployment of smart glass electronic equipment.

Similar orders have been implemented in the Department of Transport within the U.S., the EU territories, and the UK. For instance, the utilization of Google Glass may be banned within the UK owing to growing concerns related to reckless driving. In addition, certain automotive laws have also limited the application of glazes and tint on automotive windows for maintaining a particular degree of security on road.

Global Pain Management Therapeutics Market Restrained by Expiry of Patents, Marketing Exclusivity

Pain management therapeutics are an important class of medicines dealing with reducing and eliminating pain. Pain can originate due to several types of disorders, though tissue damage is the proximal source of pain. The wide-ranging etiology of pain, which medicine treats as a symptom rather than a condition in itself, means that pain management therapeutics have to be similarly versatile, depending on the intensity and the cause of the pain. The debilitating effect of chronic or severe pain on a patient’s quality of life is the primary reason why pain management therapeutics have become so important in modern medicine. 

According to a new report released recently by Transparency Market Research, the global pain management therapeutics market was valued at US$40.9 bn in 2011. The market is expected to exhibit a -5.5% CAGR from 2012 to 2018, ending up at a valuation of close to US$29.5 bn. 

Patent Expirations Restrict Global Pain Management Therapeutics Market

There has been a notable spike in the prevalence of conditions causing chronic pain in the last few decades. Modern phenomena such as the increasing pollution and the increasing adherence to a sedentary lifestyle have contributed to this to no small degree. This has been a major driver for the global pain management therapeutics market and will continue to be a major factor in the market’s growth trajectory in the coming years.

The expected expansion in the availability of healthcare services in emerging countries is also beneficial for the global pain management therapeutics market, as more individuals will be able to get diagnosed with and treated for chronic pain conditions.

However, the expiry of various major products in the global pain management therapeutics market, such as Lyrica (pregabalin) and Cymbalta (duloxetine) – developed by Pfizer and Eli Lilly, respectively – has hurt the prospects of the global market. The loss of marketing exclusivity of these products is likely to result in increased market prospects for generic drug manufacturers. The organized pain management therapeutics market can deal with this restraint by innovating new formulations for pain management, something the industry hasn’t achieved so far.

Browse Report: http://www.transparencymarketresearch.com/pain-management-therapeutics.html

NSAIDs Largest Product Segment, North America Major Regional Market for Pain Management Therapeutics

By product type, the global pain management therapeutics market is segmented into opioids, non-steroidal anti-inflammatory agents (NSAIDs), antidepressants, anti-migraine agents, and anticonvulsants. NSAIDs accounted for the largest share in the global pain management therapeutics market in 2011 and are likely to remain one of the largest segments of the market in the coming years.

Regionally, North America accounted for more than half of the global pain management therapeutics market in 2011, with a valuation of US$21.7 bn. Even though the North America market will remain the largest regional pain management therapeutics market in the coming years, both its valuation and its share in the global market are likely to drop over the forecast period. The North America market for pain management therapeutics is expected to be valued at close to US$14.3 bn by 2018, less than 50% of the global market’s expected 2018 valuation.

IMO Regulations and Government Efforts to Encourage Usage of LNG as a Bunker Fuel across Shipping Industry

An Increasing number of ships and vessels are using liquefied natural gas or LNG as a clean fuel to comply with the regulations laid by the International Maritime Organization (IMO) across emission control areas. LNG as a ship fuel reduces the emission of sulphur dioxide by 90-95% compared to the conventional petroleum fuels. This factor has propelled the growth of the global LNG bunkering market. The market stood at 70 kilo tons in 2013 and is anticipated to expand phenomenally at a CAGR of 63.6% during the period between 2014 and 2025. The overall market is projected to reach 22,540 kilo tons by 2025.

What are the key factors hindering the expansion of the global LNG bunkering market?

The lack of LNG fuelling infrastructure across the major bunkering destinations is one of the primary factors impeding the growth of the LNG bunkering market worldwide. The high cost of building LNG fuel ships has slowed down their adoption among the shipping companies. Furthermore, the storage of LNG at low temperature of about -162 degree Celsius poses as a key challenge to its usage as a marine fuel. The necessary additional safety measures for the storage of LNG increases the cost of production and designing of LNG-fuelled vessels. As a result, a number of shipping companies are resorting to alternative approaches to meet the IMO regulations. 

Research Report: http://www.transparencymarketresearch.com/lng-bunker-fuel-market.html

How is the LNG bunkering market across Asia Pacific evolving?

In Asia Pacific, South Korea and China are among the key countries that are investing significantly on LNG as a bunker fuel. Countries such as Singapore are fast adopting LNG as a sustainable alternative source of fuel in the maritime industry. The Maritime and Port Authority of Singapore has recently announced the extension of the Green Ship Programme (GSP) incentives to ships that are using LNG as fuel. The Singapore government is taking efforts to cut down the emission of sulphur and carbon dioxide. The GSP has been started to encourage the domestic maritime industry to contribute towards the conservation of environment.

Under this programme, Singapore-flagged ships are entitled to reduction in initial registration fees and tax rebate on annual tonnage. With this effort, over 50% of the ships qualified for the programme have exceeded the present Energy Efficiency Design Index set up by the IMO.

On the other hand, the Indian government is trying to reduce carbon emissions without extra operating costs. The Ministry of Shipping has announced that Petronet LNG Ltd. will be working with the Inland Waterways Authority of India to develop the operation of LNG barges on the river Ganga by December 2018. All these recent developments are expected to immensely support the adoption of LNG as a bunker fuel in Asia Pacific.

Offshore Wind Energy Installed Capacity to Reach 52,120.9 MW by 2022 owing to Favourable Regulatory Environment across Europe

The growing focus on renewable energy and the advantages offered by offshore wind energy over its onshore counterpart have led to greater installations of offshore wind energy. Favourable regulatory framework, incentives, and investments by key market players have further supported the market’s growth. The global installed capacity in the offshore wind energy market is anticipated to expand at a CAGR of 25% during the period between 2014 and 2022 to reach 52,120.9 MW by 2022.

How is the offshore wind energy market in Europe shaping up?

In Europe, countries such as the U.K., France, Germany, Netherlands, and Denmark are the pioneers in the offshore wind energy market and hence, Europe is the largest market for offshore wind energy. In 2013, the region reported 1,567 MW of new capacity additions in the offshore wind energy market. Germany holds about 30% of the consented offshore wind farms in Europe and has emerged as one of the leading offshore wind energy markets.

Due to the new Energy Act of 2013 and Electricity Market Reform Package, the U.K. has been the prominent market for offshore wind energy. Changes in subsidy and uncertainty over Britain’s vote to leave the European Union have spelled long shadows over the growth of the domestic offshore wind industry. Investors are worried regarding future incentives and export duties that would impact the growth of the offshore wind market in the country. 

Research Report: http://www.transparencymarketresearch.com/offshore-wind-energy-market.html

According to the Renewable UK, Britain’s renewable energy industry body, the offshore wind market in Britain is expected to reach a valuation of US$27 bn during the period between 2010 and 2020. Currently, Britain has a capacity of over 5 GW whereas Germany has 3.4 GW of installed capacity. However, in the aftermath of the recent events, offshore wind energy projects in Britain are being delayed. For example, Siemens is reconsidering plans to expand its manufacturing plant in the port of Hull across northeast of England.

Why are the key players in global offshore wind energy market focussing on Asia Pacific?

Some of the major players in the global offshore wind energy market are Nordex, Suzlon, China Ming Yang Wind Power, Dong Energy, Sinovel Win, Gamesa, Vestas, GE Wind Energy, and Siemens. Though Europe is the leading region in the market, the key players are channelizing their efforts in expanding their business across Asia Pacific. The developing countries in Asia Pacific are registering an ever increasing demand for electricity and the offshore wind energy market has immense potential to grow across the region.

Presently, China is the only country with separate target allotment regarding offshore wind energy installations. The country has over 18,000 sea miles of coastline and hence, offers broad development opportunities for offshore wind projects. Companies are establishing joint ventures to tap on the opportunities in the China offshore wind energy market. For example, Singapore-based Ezion Holdings Ltd. has partnered with Sinotrans & CSC Holdings Co. Ltd. to support offshore wind power installation projects in China.

Introduction of RNA Analysis Tools and Services to Open Huge Business Prospects in Transcriptomics Technologies

There has been a shift in the focus of pharmaceuticals companies towards targeted therapeutics. This has created a demand for disease-specific biomarkers, which in turn has created opportunities in commercializing transcriptome research outcomes. Transcriptome analysis tools and services help identify novel and potential drug targets. 

Since long, the transcriptomes of stem cells and cancer cells have held the interests of researchers who strive to deeply understand how cellular differentiation or carcinogenesis take place. However, the area of study is expected to expand as researchers are now analyzing the transcriptomes of human embryos, which is expected to be a powerful tool for in vitro fertilization. Transcriptomics is thus, a technology that is continually growing in the field of biomarker discoveries and is extensively used to assess the safety of drugs. 

According to a research report by Transparency Market Research (TMR), the global transcriptomics technologies market will rise from US$1.65 bn in 2012 to US$4.6 bn by the end of 2019 expanding at a healthy CAGR of 15.90% between 2013 and 2019. 

In this blog post, TMR answers three critical questions about the global transcriptomics technologies market:

Q. What are the latest trends in the transcriptomics technologies market?

The transcriptomics technologies market is currently witnessing the partnering of many software companies with life science equipment manufacturers. The partnership is done with a vision to introduce reliable and sophisticated software, which enables easy handling of huge volumes of research data. Thus, it is expected that there will be interdependence between the IT industries and life science equipment manufacturers.

Some of the partnerships and acquisitions between IT companies and life sciences equipment manufacturers include: The acquisition of Ingenuity Systems, Inc., based in the U.S. by Qiagen N.V., has enabled web-based applications to handle the growing volumes of research data. Likewise, DNAStar, Inc., a company headquartered in Madison, has entered into an agreement with Life Technologies Corporation to market its software. 

Another trend, which is emerging in the market, is the mutual collaboration of pharmaceutical companies with research and academic institutions. The outsourcing of research in transcriptomics not only provides a good business opportunity to pharmaceutical companies, but benefits the diagnostic manufacturers as well. Such strategic moves are helping pharmaceutical and in-vitro diagnostics companies to reinforce their business presence and help increase their revenue generation.

Q. What are the challenges that the transcriptomics technologies market is expected to face?

The transcriptomics technologies market is expected to be inhibited by the rising difficulty in the management of complex data. Data complexity increases with the advancements in RNA analysis procedures. For instance, the analysis of the data acquired after the sequencing of multiple transcripts is expected to pose a major concern in transcriptomics research as it generates huge, unmanageable research findings or data. 

Dearth of inefficient data analysis tools will be another challenge impeding the growth of the market. There are very few people who have expertise in the field of transcriptomics technologies. This lack of expertise is preventing the transcriptomics technologies market to grow freely. 

Browse Report: http://www.transparencymarketresearch.com/transcriptomics-technologies-market.html

Q. What does the future hold for transcriptomics technologies?

With the introduction of RNA analysis tools and services, the next generation sequencing platform, huge business prospects are expected to open in transcriptomics research. The increasing demand for precision medicine will lead to a growth in transcriptomics research and also increase the degree of its commercialization. 

The current need for exploiting opportunities in developing novel drug discovery will give rise to assay technologies, multiplexed RNA quantification, and gene expression patterns of specific genes. Thus, the forthcoming era of transcriptomics research is expected to bring rapid advances in the field of drug discovery. As such, the price of new drugs is expected to reduce in the future and most importantly there will be elimination or reduction in the prospect of hypothesis failure. 

Global Cord Blood Banking Services Market Driven by Rising Awareness, Government Support

Cord blood banking refers to blood banks that specialize in storing stem cells from the umbilical cord blood. Cord blood and the stem cells it contains are becoming increasingly important in the global medical scenario due to the ability of stem cells to develop into various types of human cells. This ability has made their use practically imperative in several medical fields that deal with tissue and organ damage. The rising awareness about the utility of cord blood has driven the global cord blood banking services market and will continue to be a major factor in the market’s growth trajectory in the coming years.

According to a market report recently released by Transparency Market Research, the global cord blood banking services market was valued at US$12.4 bn in 2012. Exhibiting a steady 5.60% CAGR from 2013 to 2019, the market is expected to rise to a valuation of US$15.2 bn. 

What are the major drivers for the global cord blood banking services market?

Since cord blood and the stem cells that are a part thereof can only be obtained at the culmination of a pregnancy, making parents more aware of the benefits of cord blood banking has emerged as a major driver for the global market. Several developed countries have been moderately successful in educating a significant part of the population about cord blood banking, which has allowed the market to establish a firm foothold in regions such as North America and Western Europe. Not only is cord blood banking a public good, but having access to cord blood stem cells also increases the chances of the baby’s own successful recovery from various diseases at any point in its life. 

The global cord blood banking services market has also been driven by the rapid technological development observed in the sector, which has led to the process steadily becoming safer and more reliable. This has also been helped by the active role played by various healthcare bodies in spreading awareness about cord blood donation. 

Browse Report: http://www.transparencymarketresearch.com/cord-blood-banking-services.html

Why is it important to support the development of public cord blood banks?

The lack of public cord blood banks on a large scale has held the global cord blood banking services market back. While private cord blood banks store cord blood for use on the individual and their immediate family only, public cord blood banks operate as a network to supply cord blood wherever it is needed – much like a regular blood bank. While private cord blood banks are the more popular type of cord blood banks at present, public banks are expected to steadily increase in number over the next few years due to the growing government support afforded to this field.

Stem cells can help cure some of today’s deadliest and most widely prevalent diseases, such as leukemia, lymphoma, several disorders regarding proliferation of blood, and several congenital disorders. The use of stem cells in treating autoimmune diseases, cardiac diseases, and neurological diseases is also under trial and is likely to come to the fore in the coming years as long as the government support to this sector remains steady.

What are the major regional players in the global cord blood banking services market?

North America dominated the global cord blood banking services market in 2013 and is likely to retain the position over the forecast period. However, Asia Pacific is the market to be for cord blood banking market players in the coming years, as government support to healthcare upgrades is rising in this region and the increasing urban population is becoming both more aware about cord blood banking and capable of paying the relatively high prices of cord blood banking services. As prices level out over the coming years with increasing demand, Asia Pacific could well become the dominant regional market for cord blood banking services.